Literature DB >> 14564519

Expression of ICAM-1 in colon epithelial cells: an ultrastructural study performed on in vivo and in vitro models.

Ben Vainer1, Susanne Sørensen, Jakob Seidelin, Ole Haagen Nielsen, Thomas Horn.   

Abstract

BACKGROUND: Studies have suggested that in ulcerative colitis (UC), intercellular adhesion molecule-1 (ICAM-1) is involved in migration of leukocytes toward the colonic epithelium. A suitable in vitro model of chronic colonic inflammation does not exist, and the role of the epithelium is based on monolayers of cancer cells. Conflicting results exist on epithelial ICAM-1 expression, and the aim of this study was to compare the expression in various models of colonic epithelium.
MATERIALS AND METHODS: Colonic biopsies from four UC patients and four controls were examined by cryoimmuno-electron microscopy using ICAM-1-antibodies. In four other controls, the epithelium was isolated from colonic biopsies, embedded in collagen, and evaluated similarly. Isolated crypts and cultured cancer cells were stimulated with interferon-gamma (IFN-gamma) or tumor necrosis factor-alpha (TNF-alpha).
RESULTS: ICAM-1 was not expressed in the biopsies. In contrast, HT29 cells and the collagen-embedded crypts expressed ICAM-1 on the apical membranes proximal to the junctional complexes when stimulated with IFN-gamma or TNF-alpha in a dose-related manner.
CONCLUSIONS: ICAM-1 is not expressed on colonic epithelium in vivo. However, both colonocytes and HT29 cells were capable of expressing ICAM-1 on their apical membranes in response to supraphysiologic cytokine concentrations. These observations question the justification of extrapolating observations from colon cancer cell lines to in vivo inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564519     DOI: 10.1007/s00428-003-0900-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

1.  Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease.

Authors:  B Vainer; O H Nielsen; T Horn
Journal:  Am J Surg Pathol       Date:  2000-08       Impact factor: 6.394

2.  Chemotactic properties of ICAM-1 and PECAM-1 on neutrophil granulocytes in ulcerative colitis: effects of prednisolone and mesalazine.

Authors:  B Vainer; O H Nielsen
Journal:  Aliment Pharmacol Ther       Date:  2000-08       Impact factor: 8.171

3.  Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines.

Authors:  D Kaiserlian; D Rigal; J Abello; J P Revillard
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

4.  Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR.

Authors:  M Komatsu; D Kobayashi; K Saito; D Furuya; A Yagihashi; H Araake; N Tsuji; S Sakamaki; Y Niitsu; N Watanabe
Journal:  Clin Chem       Date:  2001       Impact factor: 8.327

5.  Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease.

Authors:  G Malizia; A Calabrese; M Cottone; M Raimondo; L K Trejdosiewicz; C J Smart; L Oliva; L Pagliaro
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

6.  Adhesion molecules in inflammatory bowel disease.

Authors:  S C Jones; R E Banks; A Haidar; A J Gearing; I K Hemingway; S H Ibbotson; M F Dixon; A T Axon
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

7.  Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils.

Authors:  C A Parkos; S P Colgan; M S Diamond; A Nusrat; T W Liang; T A Springer; J L Madara
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

8.  Absence of circulating interferon in patients with inflammatory bowel disease. Suggestion against an autoimmune etiology.

Authors:  M R Capobianchi; S Fais; M C Di Paolo; D Agostini; P Paoluzi; F Pallone; F Dianzani
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

9.  Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells.

Authors:  W Dippold; B Wittig; W Schwaeble; W Mayet; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

10.  Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease.

Authors:  G M Schuermann; A E Aber-Bishop; P Facer; J C Lee; D S Rampton; C J Doré; J M Polak
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

View more
  4 in total

1.  GM6001 Increases Anastomotic Leakage following Colonic Obstruction Possibly by Impeding Epithelialization.

Authors:  Martin Rehn; Peter-Martin Krarup; Lise H Christensen; Jakob B Seidelin; Magnus S Ågren; Ingvar Syk
Journal:  Surg Infect (Larchmt)       Date:  2015-07-14       Impact factor: 2.150

2.  Human colonic crypts in culture: segregation of immunochemical markers in normal versus adenoma-derived.

Authors:  Michael K Dame; Yan Jiang; Henry D Appelman; Kelly D Copley; Shannon D McClintock; Muhammad Nadeem Aslam; Durga Attili; B Joseph Elmunzer; Dean E Brenner; James Varani; D Kim Turgeon
Journal:  Lab Invest       Date:  2013-12-23       Impact factor: 5.662

3.  Effect of traditional Chinese medicinal enemas on ulcerative colitis of rats.

Authors:  Song-Ming Guo; Hong-Bin Tong; Lian-Song Bai; Wei Yang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

4.  Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.

Authors:  C Dianzani; L Brucato; M Gallicchio; A C Rosa; M Collino; R Fantozzi
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.